Back to Results
First PageMeta Content
Catheters / Hemodialysis / Nephrology / Fistula / Arteriovenous fistula / Central venous catheter / Dialysis / Peripheral venous catheter / Cimino fistula / Medicine / Renal dialysis / Membrane technology


Novel Endovascular Access Trial Patient FAQ 1. What is the NEAT study? The Novel Endovascular Access Trial (NEAT) clinical study recently began enrolling patients with chronic kidney disease (CKD) in Canada to study the
Add to Reading List

Document Date: 2014-10-31 11:02:11

Open Document

File Size: 142,59 KB

Share Result on Facebook

City

Montreal / Oshawa / Austin / /

Company

TVA Medical Inc. / INVESTIGATIONAL DEVICE LIMITED / /

Continent

South America / /

Country

Canada / Australia / New Zealand / /

Facility

Victoria Hospital / Paul’s Hospital / Toronto General Hospital / Alfred Hospital / University Health Centre / Princess Alexandra Hospital / Auckland City Hospital / /

IndustryTerm

radiofrequency energy / therapies for end-stage renal disease / /

MedicalCondition

chronic dialysis / cut / chronic kidney disease / renal disease / infection / end-stage renal disease / thrombosis / chronic hemodialysis / /

MedicalTreatment

incision / catheter / catheters / hemodialysis / surgery / dialysis / arm incision / /

Organization

Victoria Hospital in London / Montreal University Health Centre / St. Paul’s Hospital in Vancouver / Alfred Hospital in Melbourne / Auckland City Hospital in Auckland / Toronto General Hospital in Toronto / Princess Alexandra Hospital / /

/

ProvinceOrState

Texas / Queensland / Ontario / /

Technology

AV / dialysis / /

URL

www.TVAMedical.com / /

SocialTag